Navigation Links
Spine Surgeons Embrace Uniquely Effective Valeo Interbody Fusion Devices As Amedica Announces 10,000 Implantations
Date:3/22/2013

SALT LAKE CITY, March 22, 2013 /PRNewswire/ -- Amedica Corporation, a spinal and reconstructive medical device manufacturer, today announced the 10,000th worldwide implantation of its Valeo Interbody Fusion Devices. The Valeo Interbody Fusion Device System, made of Amedica's proprietary Silicon Nitride ceramic technology, is used during surgical procedures to treat spinal disorders such as spondylolisthesis, scoliosis, severe disc degeneration, or spinal fractures.

Due to its proven record of superior new bone growth and antibacterial properties, surgeons at leading hospitals worldwide are increasingly relying on Valeo Silicon Nitride Interbody Fusion Devices to increase the probability of fusion.

"In my four years of experience with Silicon Nitride Interbody Fusion Devices, I've seen the material exceed the capabilities of poly-ether-ether-ketone (PEEK) and titanium (Ti), resulting in better fusion, which translates to better results for my patients," said Dr. Grant Skidmore of Neurosurgical Specialists, Inc., in Norfolk, Va. "As a spinal surgeon, my paramount concern is getting my patients back to their daily activities as soon as possible. Patients who I've treated with Valeo implants have had a quicker recovery time compared to traditional implants."

The Valeo Interbody Fusion Device System includes cervical and lumbar implants designed to participate in the fusion process, optimizing patient outcomes. The implants are semi-radiolucent allowing surgeons to ascertain exact placement intra-operatively and improve post-operative monitoring.  Valeo Interbody Fusion Devices do not cause MRI or CT artifacts which can make imaging interpretation difficult. 

"The success of the Valeo Interbody Fusion Device System is a testament to the proven safety and effectiveness of our Silicon Nitride technology," said Eric K. Olson , President and Chief Executive Officer, Amedica. "As we continue to work toward a new standard of care for interbody fusion devices, we are pleased to see a continued increase in physician adoption. We are greatly encouraged for the future of this technology."

Additional information about the Company's complete line of products may be found at www.amedica.com.

About Amedica Corporation:

Amedica is an innovative spine and orthopaedic implant and device manufacturing and distribution company that provides advanced surgical applications made possible with the use of its silicon nitride ceramic technologies.  Amedica is a privately held, private equity backed company founded in 1996 by internationally recognized orthopaedic surgeons and ceramicists. The company is ISO 13485 certified, its spine products are FDA cleared, CE marked, and sold in ten countries. Amedica Corporation is based in Salt Lake City, UT.

Media Contact
Stacey Holifield / Stacy Nartker
Schwartz MSL
(781) 684-0770
AMEDICA@schwartzmsl.com


'/>"/>
SOURCE Amedica Corporation
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Paradigm Spine Welcomes Hallett Mathews, MD, MBA As Its Executive Vice President & Chief Medical Officer
2. Comprehensive Spine Symposium: Sept. 21
3. International Spine Products Manufacturer Featured in Upcoming US Business Executive Publication - www.gsmedicalusa.com
4. Interventional Spine Announces its 75th Patient Treated with the PerX360 Percutaneous Spinal Fusion Technology
5. SpineMark Corporation Partners with PhDx and Millennium Environmental to Create an ISO type Spine Protocol Management System
6. Misonix Adds 6 Spine Sales Agencies In The U.S.
7. Global Information Inc Offers Big Discounts on Market Forecasts for Surgical Sealants, Wound Closure Products, Spine Surgery Technology, and More
8. Boston Scientific Announces Promising Clinical Data on New Products at the International Spine Intervention Society 20th Annual Scientific Meeting
9. Misonix Attends International Meeting On Advanced Spine Techniques (IMAST) - Introduces New Product
10. Misonix Participates In Cleveland Spine Review
11. Misonix Exhibits at Major Worldwide Spine Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... , March 27, 2017   Pulmatrix, Inc . (NASDAQ: ... to address serious pulmonary diseases, today announced that it has ... cystic fibrosis and asthma to its Scientific Advisory Board ... Richard B. Moss , MD, former chief of ... the Cystic Fibrosis Center at Stanford University, and ...
(Date:3/27/2017)... March 27, 2017  BERG, a biopharmaceutical ... biological research approach, today announced that the ... discovery of new data using a cold-induced ... fat metabolism. Joslin Diabetes Center led the ... platform for analysis of samples.  The findings ...
(Date:3/27/2017)... , March 27, 2017 ... as the NASDAQ Composite closed the trading session up ... and the S&P 500 was down 0.08%. US markets ... sectors finishing the day in green. Pre-market today, Stock-Callers.com ... Medical Group N.V. (NASDAQ: WMGI), Amedica Corporation (NASDAQ: AMDA), ...
Breaking Medicine Technology:
(Date:3/27/2017)... (PRWEB) , ... March 27, 2017 , ... ... business simulation -centric training, today announced the launch of a new research study, ... having the skills needed to execute that strategy, and the actual success of ...
(Date:3/27/2017)... Georgia (PRWEB) , ... March 27, 2017 , ... ... to announce that for a second year in a row; they are the ... healthcare designers in the industry voted on the award at Design Connections 2017. ...
(Date:3/27/2017)... ... ... still in shock after receiving a $2,500 Academic Award from California Casualty . “This ... She thinks the coming week is going to be a very joyful for her classroom. ... students.” , The award will allow the 4th grade teacher at Tumwater Hill Elementary School ...
(Date:3/27/2017)... ... March 27, 2017 , ... The Anaheim Hills office ... First National Capital has added 10 new sales professionals over the past 6 months ... by 15 additional new hires over the course of 2017. , “This new ...
(Date:3/27/2017)... ... March 27, 2017 , ... ... announce the launch of a months-long rebranding effort. This includes the introduction of ... focus group discussions and market research, we learned that a simple, proactive approach ...
Breaking Medicine News(10 mins):